Share on LinkedInShare on LinkedIn

ARTICLE · 16 JULY 2025

Not So Obvious: You Won't Believe How This Simple Dosing Change Became Worth Billions

Imagine you're a generic drug manufacturer, and you've spotted what looks like a billion-dollar opportunity. There's a blockbuster psychiatric medication called "paliperidone palmitate" that...

JapanIntellectual Property

Introduction

Imagine you're a generic drug manufacturer, and you've spotted what looks like a billion-dollar opportunity. There's a blockbuster psychiatric medication called “paliperidone palmitate” that costs patients hundreds of dollars per month, and you think you can prove that the key patent protecting it is invalid. The drug itself is not new or even patented but the method of dosing the drug through a series of injections is claimed in a patent, U.S. Patent No. 9,439,906 (“the '906 patent”).

Here's your strategy. You'll file an application with the FDA to essentially make a copy of the brand-name drug in what's called an “Abbreviated New Drug Application” or “ANDA”—that's how generic approval works under the Hatch-Waxman Act. You know this will inevitably trigger a patent lawsuit, but you're not worried. In fact, you're counting on it.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from